EU Issues First-Ever GMP Annex on Artificial Intelligence: 10 Key Compliance Requirements for Pharmaceutical AI
Brussels, July 7, 2025 — The European Commission and PIC/S (Pharmaceutical Inspection Co-operation Scheme) have jointly released the draft “GMP Annex 22: Artificial Intelligence (AI)”, launching a ...
More+
Center for Drug Evaluation (CDE) Issued the Notification of “Technical Guideline for the Pharmaceutical Study and Evaluation of Ex-vivo Genetic Modification System (Interim)” (No. 29, 2022)
In order to standardize and guide the pharmaceutical research of in vitro gene modification systems, under the deployment of the National Drug Administration, the Drug Evaluation Center organized the ...
More+
FDA Adds Boxed Warning to Johnson & Johnson and Legend Biotech’s CAR-T Therapy Carvykti
October 10, 2025 — Washington, D.C. — The U.S. Food and Drug Administration (FDA) has issued a new safety update for Carvykti (ciltacabtagene autoleucel), a CAR-T cell therapy co-developed by Johnso...
More+
Center for Drug Evaluation (CDE) Issued the Notification of “Technical Guideline for the Pharmaceutical Study and Evaluation of Cell-based Immunotherapy Products (Interim)” (No. 30, 2022)
In order to standardize and guide the pharmaceutical research and development, production and registration of immune cell therapy products, under the deployment of the National Medical Products Admini...
More+
Experimental Gene Therapy Restores Immune Systems in Children with Deadly Disorder
An international research collaboration between UCLA, University College London (UCL), and Great Ormond Street Hospital has achieved a breakthrough in treating a fatal childhood immune disorder, adeno...
More+
Center for Drug Evaluation (CDE) Issued the Notification of “Technical Guideline for the Pharmaceutical Study and Evaluation of In-vivo Gene Therapy Products (Interim)” (No. 31, 2022)
In order to standardize and guide the pharmaceutical research and development, production and registration of in vivo gene therapy products, under the deployment of the National Medical Products Admin...
More+
McKesson Report: Cell and Gene Therapies Grow Rapidly, but Cost and Access Gaps Persist
October 2025 · Irving, Texas — McKesson Corporation, one of the world’s leading healthcare service and distribution companies, has released its latest industry report showing that while cell and ge...
More+
CDE issued “Guidelines on Clinical Trial Statistics of Drug Products for Rare Diseases (Interim)”
In order to encourage the development of drugs for rare diseases and guide applicants to improve R&D efficiency from the perspective of clinical research methodology, the Drug Evaluation Center or...
More+